AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 261: R145-R153, 1991;
0363-6119/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorn, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorn, G. W., 2nd

AJP - Regulatory, Integrative and Comparative Physiology, Vol 261, Issue 1 145-R153, Copyright © 1991 by American Physiological Society


ARTICLES

Tissue- and species-specific differences in ligand binding to thromboxane A2 receptors

G. W. Dorn 2nd
University of Texas Health Science Center, San Antonio.

The ligand binding site of vascular smooth muscle (VSM) and platelet thromboxane A2 (TxA2) receptors was characterized in humans and rabbits using the TxA2 mimetic [125I]BOP. Vessel contraction and platelet aggregation studies demonstrated that unlabeled I-BOP and the prostaglandin H2 (PGH2) mimetic U-46619 were potent agonists in rabbit aortas, human saphenous veins, and washed human and rabbit platelets. [125I]BOP bound saturably to a single site on cultured vascular smooth muscle (VSM) cells from rabbit aortas and human saphenous veins with dissociation constants (Kd) of 392 +/- 8 (n = 5) and 390 +/- 120 pM (n = 6) and binding capacities (Bmax) of 5,322 +/- 200 and 2,017 +/- 322 sites/cell, respectively. [125I]BOP also bound saturably to one site on rabbit platelets (Kd = 415 +/- 15 pM, Bmax = 594 +/- 43 sites/platelet, n = 4) but, in agreement with previous studies, to two sites on human platelets (high-affinity Kd = 118 +/- 24 pM, Bmax = 121 +/- 33 sites/platelet; low-affinity Kd = 1.1 +/- 0.47 nM, Bmax 232 +/- 23 sites/platelet, n = 4). [125I]BOP was displaced from its binding site on rabbit and human VSM and platelets by stable TxA2/PGH2 analogues possessing either agonist or antagonist activity but not by other prostaglandins. The rank orders of the binding inhibition constants (IC50) for the TxA2/PGH2 analogues were compared among the four tissues and were highly correlated (r = 0.963) in VSM and platelets from rabbits but not humans (r = 0.699), suggesting that human VSM TxA2 receptors may be distinct from platelet TxA2 receptors. The IC50 rank order was also highly correlated (r = 0.935) between human and rabbit platelets.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. W. Dorn II, M. G. Davis, and D. D. D'Angelo
Structural Determinants for Agonist Binding Affinity to Thromboxane/Prostaglandin Endoperoxide (TP) Receptors. ANALYSIS OF CHIMERIC RAT/HUMAN TP RECEPTORS
J. Biol. Chem., May 9, 1997; 272(19): 12399 - 12405.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Habib, R. Vezza, C. Creminon, J. Maclouf, and G. A. FitzGerald
Rapid, Agonist-dependent Phosphorylation in Vivo of Human Thromboxane Receptor Isoforms. MINIMAL INVOLVEMENT OF PROTEIN KINASE C
J. Biol. Chem., March 14, 1997; 272(11): 7191 - 7200.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online